Brief: Hemogenyx Pharmaceuticals Amends Clinical Protocol For HG-CT-1
14/05/2025 08:16
May 14 (Reuters) - Hemogenyx Pharmaceuticals PLC HEMO.L: HEMOGENYX PHARMACEUTICALS: AMENDMENT TO CLINICAL PROTOCOL FOR HG-CT-1 TO INCLUDE PEDIATRIC PATIENTS WITH R/R AML Further company coverage: HEMO.L ((Reuters.Briefs@thomsonreuters.com;))